価格表

在庫・価格 : 2026年04月12日 00時15分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Aflatoxin B1, Mouse-Mono(6A10)
データシート※最新のデータシートでない場合があります
NB600-443SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥41,000
(未発注)
追加

在庫・価格 : 2026年04月12日 00時15分 現在

Anti-Aflatoxin B1, Mouse-Mono(6A10)

  • 商品コード:NB600-443SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Chen CJ et al. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Hepatology 1992 Nov;16(5):1150-5
Chen CJ et al
1992/01/01
PubMed
2 Zhang YJ et al. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis 1991 Dec;12(12):2247-52
Zhang YJ et al
1991/01/01
PubMed
3 Qi LN et al. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Liver Int. 2014 Jan;
Qi LN et al
2014/01/01
Applications: IHC-P PubMed
4 Ochsner UA et al. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model. J. Antimicrob. Chemother. 2009 May;63(5):964-71
Ochsner UA et al
2009/01/01
Applications: WB PubMed
5 Besaratinia A et al. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 2009 Sep;137(3):1127-37, 1137.e1-5
Besaratinia A et al
2009/01/01
Applications: WB, DB PubMed
6 Shirabe K et al. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Liver Int. 2011 Oct;31(9):1366-72
Shirabe K et al
2011/01/01
Applications: IHC-P PubMed
7 Lu JW et al. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish. Acta Histochem. 2013 Mar;
Lu JW et al
2013/01/01
Species: Zebrafish, Applications: IHC-P PubMed
8 Yarborough A et al. Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 1996 Feb;56(4):683-8
Yarborough A et al
1996/01/01
Applications: IHC-Fr PubMed
9 Qi LN et al. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China. PLoS ONE 2013;8(12):e83465
Qi LN et al
2013/01/01
Applications: IHC-P PubMed
10 Lunn RM et al. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999 Jun;59(11):2557-61
Lunn RM et al
1999/01/01
Applications: PubMed
11 Yang XJ et al. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology 2012 Oct;300(3):138-48
Yang XJ et al
2012/01/01
Species: Human, Applications: IHC PubMed
12 Hsieh LL et al. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res. 1988 Nov;48(22):6328-31
Hsieh LL et al
1988/01/01
Applications: ELISA PubMed
13 Long XD et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer 2009;9:400
Long XD et al
2009/01/01
PubMed
14 Huang XY et al. MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis. Gastroenterol Res Pract 2013;2013:804128
Huang XY et al
2013/01/01
Applications: ELISA PubMed
15 Hsieh LL et al. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer Res. 1993 Mar;53(6):1278-80
Hsieh LL et al
1993/01/01
PubMed
  • No.: 1
  • 文献情報:
    Chen CJ et al. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Hepatology 1992 Nov;16(5):1150-5
    Chen CJ et al
    1992/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zhang YJ et al. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis 1991 Dec;12(12):2247-52
    Zhang YJ et al
    1991/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Qi LN et al. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure. Liver Int. 2014 Jan;
    Qi LN et al
    2014/01/01
  • 備考:
    Applications: IHC-P
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ochsner UA et al. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model. J. Antimicrob. Chemother. 2009 May;63(5):964-71
    Ochsner UA et al
    2009/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Besaratinia A et al. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 2009 Sep;137(3):1127-37, 1137.e1-5
    Besaratinia A et al
    2009/01/01
  • 備考:
    Applications: WB, DB
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Shirabe K et al. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan. Liver Int. 2011 Oct;31(9):1366-72
    Shirabe K et al
    2011/01/01
  • 備考:
    Applications: IHC-P
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Lu JW et al. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish. Acta Histochem. 2013 Mar;
    Lu JW et al
    2013/01/01
  • 備考:
    Species: Zebrafish, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Yarborough A et al. Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 1996 Feb;56(4):683-8
    Yarborough A et al
    1996/01/01
  • 備考:
    Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Qi LN et al. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China. PLoS ONE 2013;8(12):e83465
    Qi LN et al
    2013/01/01
  • 備考:
    Applications: IHC-P
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Lunn RM et al. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999 Jun;59(11):2557-61
    Lunn RM et al
    1999/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yang XJ et al. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells. Toxicology 2012 Oct;300(3):138-48
    Yang XJ et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Hsieh LL et al. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res. 1988 Nov;48(22):6328-31
    Hsieh LL et al
    1988/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Long XD et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer 2009;9:400
    Long XD et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Huang XY et al. MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis. Gastroenterol Res Pract 2013;2013:804128
    Huang XY et al
    2013/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Hsieh LL et al. Detection of aflatoxin B1-DNA adducts in human placenta and cord blood. Cancer Res. 1993 Mar;53(6):1278-80
    Hsieh LL et al
    1993/01/01
  • 備考:
  • 参照:
    PubMed